Viral vector production costs have a disproportionate influence on gene therapy prices, so choosing the virus manufacturing method that fits the product and its intended patient population is critical ...
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results